Medical Transcription Billing (NASDAQ:MTBC) Coverage Initiated by Analysts at B. Riley

Stock analysts at B. Riley began coverage on shares of Medical Transcription Billing (NASDAQ:MTBC) in a research note issued to investors on Tuesday, BenzingaRatingsTable reports. The brokerage set a “buy” rating and a $6.25 price target on the technology company’s stock. B. Riley’s price target would indicate a potential upside of 53.56% from the stock’s previous close.

A number of other research analysts have also recently weighed in on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 price objective on shares of Medical Transcription Billing in a report on Tuesday, October 15th. National Securities initiated coverage on shares of Medical Transcription Billing in a research report on Thursday, October 10th. They issued a “buy” rating and a $6.00 price objective for the company. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $6.08.

NASDAQ:MTBC opened at $4.07 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.31 and a quick ratio of 2.27. The firm has a market cap of $49.79 million, a price-to-earnings ratio of -6.90 and a beta of 1.77. The company has a 50 day moving average price of $3.88 and a 200-day moving average price of $4.42. Medical Transcription Billing has a 1-year low of $3.25 and a 1-year high of $5.50.

Medical Transcription Billing (NASDAQ:MTBC) last posted its earnings results on Wednesday, November 6th. The technology company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). Medical Transcription Billing had a negative net margin of 5.01% and a negative return on equity of 8.85%. The firm had revenue of $16.85 million during the quarter, compared to analysts’ expectations of $16.06 million. On average, sell-side analysts anticipate that Medical Transcription Billing will post -0.56 earnings per share for the current fiscal year.

In other Medical Transcription Billing news, Director John N. Daly sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $3.57, for a total transaction of $35,700.00. Following the transaction, the director now owns 106,900 shares in the company, valued at $381,633. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 18,000 shares of company stock worth $66,506 in the last quarter. 50.50% of the stock is currently owned by company insiders.

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

See Also: What does relative strength index mean?

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.